The drug, from Sarepta Therapeutics, promises to repair the defective gene at the root of the fatal disorder, but is expected to cost millions of dollars.
The Price of First Gene Therapy for Muscular Dystrophy: $3.2 Million
Wall Street Journal - 22 Jun 2023 23:17
The drug, from Sarepta Therapeutics, promises to repair the defective gene at the root of the fatal disorder, but is expected to cost millions of dollars.
Share this Article
Recommended